BUY Apollo Hospitals Enterprise Ltd. — Rupak De, LKP Securities
byRupak De, LKP SecuritiesHorizon: NA (inferred 1–3 months)19 Aug 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·7 Sept · today
7 advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·26 Aug · 2w ago
Apollo Hospitals: अब रविवार को भी खुलेंगे अस्पताल, शेयर ₹8,817 पर
NewsGoogle News·18 Aug · 3w ago
Apollo Hospitals: आता रविवारीही OPD सेवा सुरु; शेअरची ₹8,817 वर“',"metaDescription": "Apollo Hospitals आता 76 रुग्णालयांमध्ये रविवारीही सेवा देणार. कंपनीची आर्थिक वाढ, कर्जाची स्थिती आणि विस्तारामुळे
NewsGoogle News·18 Aug · 3w ago
Apollo Hospitals Starts Sunday Services; Stock Trades at ₹8,817
NewsGoogle News·18 Aug · 3w ago
Apollo sets June 24 meetings for demerger scheme
NewsGoogle News·25 Aug · 2w ago
Apollo Hospitals: How Does the Company Plan to Expand Beyond Its Hospitals Business?
NewsGoogle News·19 Aug · 3w ago
Apollo Hospitals vs Max Healthcare: आर्थिक निकालांमध्ये जोरदार टक्कर, कोण ठरले अव्वल?
NewsGoogle News·16 Aug · 3w ago
Past month's volume 1.5× the prior month's average
Technicals · volume·4 Sept · 3d ago
1 other SEBI-registered advisor has an active short-term SELL call on this stock
Advisor consensus · same horizon·20 Aug · 3w ago
1 advisor has an active long-term SELL call on this stock
Advisor consensus · adjacent horizon·13 Aug · 4w ago
Hospital Stocks Slip as Panel Proposes Room Rent Caps
NewsGoogle News·11 Aug · 4w ago
Apollo Hospitals, Max Healthcare stocks fall about 1% as Parliamentary panel recommends 3-star cap on room...
NewsGoogle News·11 Aug · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.